Blood cancer Patients' samples fuel future research
NCT ID NCT01137643
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects blood, tissue, and body fluid samples from up to 15,000 people with blood cancers or related disorders. The samples are stored in a central lab for future research on diagnosis, prognosis, and immune monitoring. Participants do not receive any treatment as part of this study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599-7295, United States
Contact Phone: •••-•••-••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a diet and exercise program help childhood leukemia survivors live healthier?
- A pill that mimics the body's oxygen sensor may free MDS patients from frequent blood transfusions
- Can a cancer drug reboot the immune system after a stem cell transplant?
- Can a drug duo outsmart resistant lymphomas?
- New PET tracer could sharpen diagnosis of blood cancers
- 10,000 DNA samples could reveal hidden genetic triggers for leukemia and lymphoma